Investment Objective

A partnership with Anglo Scientific, who are experts at selecting, building and exiting from technology businesses, having invested using this strategy for over 10 years.

This EIS invests in companies that are using technology to help solve global issues predominantly in 3 sub-sectors: security; healthcare; and communications.

The companies will all have defensible IP, a truly global market, and be able to demonstrate a clear route to over £100m annually in revenues.

USP’s:

• A known portfolio of companies at time of investment
• Quick deployment of capital (circa 3 months)
• Managed by a combined team of experts – Amberside Capital and Anglo Scientific
• ALL investee companies personally invested in by the Directors of Amberside Capital/Anglo Scientific on the same terms as EIS investors

Exit Strategy

We will be targeting exits in 5-7 years from the date of investment, although it could take longer than this. These exits will likely be provided by one of the following: a trade sale, management buyout, or venture capitalist.

Exit History

Fund Manager

Amberside Capital aim to bring the highest standards of institutional management rigour to the retail investment market. This investment rigour covers all activities from the comprehensive due diligence undertaken in making investments, the detailed risk management which governs our management of investments, and the transparency we bring to investor reporting and the investment process.

Fund Adviser

Anglo Scientific are a team of entrepreneurs who set out to build high potential technology-driven companies. They aim to identify ground breaking science that can solve globally challenging problems in predominantly 3 key sub-sectors: healthcare; communications; security.

They currently have a portfolio of 9 such companies, that are collectively valued at over £200 million, from a total of £88.5m invested.

Fees

Kuber Special Arrangements

N/A